Results 91 to 100 of about 2,073,683 (216)
TRain: T-cell receptor automated immunoinformatics
Background The scarcity of available structural data makes characterizing the binding of T-cell receptors (TCRs) to peptide-Major Histocompatibility Complexes (pMHCs) very challenging.
Austin Seamann +5 more
doaj +1 more source
T-cell receptor and B-cell receptor repertoires profiling in pleural tuberculosis
BackgroundTuberculosis (TB) is a leading cause of death worldwide from a single infectious agent. In China the most common extra-pulmonary TB (EPTB) is pleural tuberculosis (PLTB).
Fengjiao Du +12 more
doaj +1 more source
Although immunodominance of CD8(+) T-cell responses is a well-recognised feature of viral infections, its role in responses to more antigenically complex pathogens is less clear.
Connelley, T. +44 more
core +1 more source
Priming of CD8+ T cell responses following immunization with heat-killed Plasmodium sporozoites.
Protective immune responses against malaria are induced by immunization with radiation-attenuated Plasmodium sporozoites. In contrast, non-viable, heat-killed sporozoites do not induce protection, emphasizing the requirement for live parasites to achieve
Morrot, Alexandre +11 more
core +1 more source
Chimeric antigen receptor T-cell therapy for T-cell acute lymphoblastic leukemia
Chimeric antigen receptor (CAR) T-cell therapy is a new and effective treatment for patients with hematologic malignancies. Clinical responses to CAR T cells in leukemia, lymphoma, and multiple myeloma have provided strong evidence of the antitumor ...
Bernice L.Z. Oh +3 more
doaj +1 more source
No life without death--apoptosis as prerequisite for T cell activation.
The orchestrated death of infected cells is key to our understanding of CD8 T cell activation against pathogens. Most intracellular bacteria including Mycobacterium tuberculosis, the etiologic agent of tuberculosis, remain enclosed in phagosomes of ...
Winau, F +7 more
core +1 more source
Chimeric antigen receptor-T cell therapy for T cell-derived hematological malignancies
Relapsed/refractory T cell-derived malignancies present with high heterogeneity and poor prognoses. Recently, chimeric antigen receptor (CAR)-T cell therapy has shown remarkable safety and efficacy in the treatment of B cell-derived malignancies. However,
Haiqiong Zheng +9 more
doaj +1 more source
TCR signal strength is involved in many cell fate decisions in the T-cell lineage. Here, we show that transcriptional events induced by Hedgehog (Hh) signaling reduced TCR signal strength in mice.
Drakopoulou, E +7 more
core

